An Intra-Hospital Spread of Colistin-Resistant K. pneumoniae Isolates-Epidemiological, Clinical, and Genetic Analysis
- PMID: 38541237
- PMCID: PMC10972034
- DOI: 10.3390/medicina60030511
An Intra-Hospital Spread of Colistin-Resistant K. pneumoniae Isolates-Epidemiological, Clinical, and Genetic Analysis
Abstract
Background and Objective: Klebsiella pneumoniae appears to be a significant problem due to its ability to accumulate antibiotic-resistance genes. After 2013, alarming colistin resistance rates among carbapenem-resistant K. pneumoniae have been reported in the Balkans. The study aims to perform an epidemiological, clinical, and genetic analysis of a local outbreak of COLr CR-Kp. Material and Methods: All carbapenem-resistant and colistin-resistant K. pneumoniae isolates observed among patients in the ICU unit of Military Medical Academy, Sofia, from 1 January to 31 October 2023, were included. The results were analyzed according to the EUCAST criteria. All isolates were screened for blaVIM, blaIMP, blaKPC, blaNDM, and blaOXA-48. Genetic similarity was determined using the Dice coefficient as a similarity measure and the unweighted pair group method with arithmetic mean (UPGMA). mgrB genes and plasmid-mediated colistin resistance determinants (mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5) were investigated. Results: There was a total of 379 multidrug-resistant K. pneumoniae isolates, 88% of which were carbapenem-resistant. Of these, there were nine (2.7%) colistin-resistant isolates in six patients. A time and space cluster for five patients was found. Epidemiology typing showed that two isolates belonged to clone A (pts. 1, 5) and the rest to clone B (pts. 2-4) with 69% similarity. Clone A isolates were coproducers of blaNDM-like and blaOXA-48-like and had mgrB-mediated colistin resistance (40%). Clone B isolates had only blaOXA-48-like and intact mgrB genes. All isolates were negative for mcr-1, -2, -3, -4, and -5 genes. Conclusions: The study describes a within-hospital spread of two clones of COLr CR-Kp with a 60% mortality rate. Clone A isolates were coproducers of NDM-like and OXA-48-like enzymes and had mgrB-mediated colistin resistance. Clone B isolates had only OXA-48-like enzymes and intact mgrB genes. No plasmid-mediated resistance was found. The extremely high mortality rate and limited treatment options warrant strict measures to prevent outbreaks.
Keywords: colistin-resistant K. pneumoniae; mgrB; mortality; outbreak; plasmid-mediated resistance.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.Ann Clin Microbiol Antimicrob. 2021 Oct 23;20(1):74. doi: 10.1186/s12941-021-00479-y. Ann Clin Microbiol Antimicrob. 2021. PMID: 34688302 Free PMC article.
-
Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae in a Tertiary Care Teaching Hospital.Front Cell Infect Microbiol. 2021 Oct 26;11:673503. doi: 10.3389/fcimb.2021.673503. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34765565 Free PMC article.
-
Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.J Glob Antimicrob Resist. 2017 Sep;10:88-94. doi: 10.1016/j.jgar.2017.03.017. Epub 2017 Jul 12. J Glob Antimicrob Resist. 2017. PMID: 28711559
-
MgrB Mutations and Altered Cell Permeability in Colistin Resistance in Klebsiella pneumoniae.Cells. 2022 Sep 26;11(19):2995. doi: 10.3390/cells11192995. Cells. 2022. PMID: 36230959 Free PMC article. Review.
-
Systematic review of multidrug-resistant Klebsiella pneumoniae in the Arabian Peninsula: molecular epidemiology and resistance patterns.Front Microbiol. 2025 Jan 24;16:1489317. doi: 10.3389/fmicb.2025.1489317. eCollection 2025. Front Microbiol. 2025. PMID: 39927260 Free PMC article.
Cited by
-
Emergence of blaNDM-5 and blaOXA-232 Positive Colistin- and Carbapenem-Resistant Klebsiella pneumoniae in a Bulgarian Hospital.Antibiotics (Basel). 2024 Jul 21;13(7):677. doi: 10.3390/antibiotics13070677. Antibiotics (Basel). 2024. PMID: 39061359 Free PMC article.
References
-
- [(accessed on 7 March 2022)]. Available online: https://apps.who.int/gb/MSPI/pdf_files/2022/03/Item1_07-03.pdf.
-
- Zimlichman E., Henderson D., Tamir O., Franz C., Song P., Yamin C.K., Keohane C., Denham C.R., Bates D.W. Health Care-associated infections. A meta-analysis of costs and financial impact on the US Health Care System. JAMA Intern. Med. 2013;173:2039–2046. doi: 10.1001/jamainternmed.2013.9763. - DOI - PubMed
-
- Magiorakos A., Srinivasan A., Carey R., Carmeli Y., Falagas M., Giske C., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. - DOI - PubMed
-
- Cassini A., Högberg L., Plachouras D., Quattrocchi A., Hoxha A., Simonsen G., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019;19:56–66. doi: 10.1016/S1473-3099(18)30605-4. - DOI - PMC - PubMed
-
- Antimicrobial Resistance in the EU/EEA (EARS-Net)—Annual Epidemiological Report for 2021. [(accessed on 17 November 2023)]. Available online: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobi....
MeSH terms
Substances
LinkOut - more resources
Full Text Sources